Pending Bayer deal keeps other corporates away
German pharmaceutical company Bayer is set to contribute to one of the largest weeks of the year by issuance volume for the corporate bond market. Other issuers are watching the developments of that deal closely and planning their own movements around it.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: